Cempra (CEMP) was annihilated on October 16th because in the reporting of the drug Solithromyocin's success in trials, increased pain at the injection point was noted. Essentially what happened n what should have been a positive note, ws that the hedge funds flinched, and sold off. this caused the stock to plummet from 26.78 on October 15, 2015 to 15.76 on...